Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Three weekly cisplatin based chemoradiation is to be compared the compliance, toxicity, and response rates with the weekly cisplatin based chemoradiation in the treatment of locoregionally advanced cervical cancers.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Korea Cancer Center Hospital
• Treatments: Cisplatin

Criteria

Inclusion Criteria:

• Histologically proven cervical cancer

• Squamous, Adenosquamous, Adeno carcinoma cell type

• International Federation of Gynecologic Oncology (FIGO) stage IIB - IVA

• Gynecologic Oncology Group (GOG) performance status 0 - 2

Exclusion Criteria:

• Previous history of chemotherapy or radiation

• History of other cancer

• Hypersensitivity to platinum agents

• Pregnancy

• Serious medical disease